Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

医学 免疫系统 抗体 免疫学 胶质母细胞瘤 癌症 免疫疗法 癌症研究 腺病毒科 抗体疗法 临床试验 抗体依赖性细胞介导的细胞毒性 免疫病理学 代理终结点 肿瘤科 细胞免疫 化疗 单克隆抗体 体液免疫 抗原
作者
Chibawanye I. Ene,S. Singh,Thiagarajan Venkataraman,Lynette M. Phillips,James P. Long,Deep Singh,Nam D. Tran,Frank Tufaro,PJ Anand,Nicholas Navin,Sujit Prabhu,J. Weinberg,H. Benjamin Larman,Candelaria Gomez-Manzano,Juàn Fueyo,F. Lang
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:32 (10): 2014-2025 被引量:1
标识
DOI:10.1158/1078-0432.ccr-25-3566
摘要

PURPOSE: The aim of the study is to evaluate the combination of intratumoral Delta-24-RGD and subcutaneous interferon gamma (IFNγ) in patients with high-grade glioma (HGG), based on the rationale that augmenting the immune response with IFNγ will increase the efficacy of Delta-24-RGD treatment. PATIENTS AND METHODS: In this phase Ib, multicenter, randomized trial (NCT02197169), we evaluated the combination of intratumorally injected Delta-24-RGD with subcutaneously administered IFNγ, a potent activator of Th1 CD8+ cell immune response, in 37 patients with recurrent HGG and investigated systemic immune correlates of long-term survival. Twenty-seven patients were randomized 2:1 into two cohorts: Delta-24-RGD (via standard biopsy needle) with IFNγ or Delta-24-RGD alone (via standard biopsy needle). In an expansion cohort, 10 patients received intratumorally injected Delta-24-RGD via the MEMS cannula. RESULTS: Although the addition of IFNγ to Delta-24-RGD did not significantly increase the percentage of long-term survivors (LTS) compared with Delta-24-RGD alone, the IFNγ cohort had the longest-surviving patients [overall survival (OS) 44.2, 23.7, 20.6, and 20.1 months]. Post hoc analysis of plasma and peripheral blood mononuclear cells using viral Phage Immunoprecipitation Sequencing Antibody Reactome profiling of viral epitopes (VirScan) and single-cell RNA sequencing revealed that levels of circulating anti-adenovirus-specific IgG and CD8+ natural killer T (NKT)-like cells 2 months after treatment with Delta-24-RGD distinguished LTS from short-term survivors. CONCLUSIONS: Immunologic fitness, assessed by an anti-adenoviral-specific antibody response and higher levels of activated CD8+ NKT-like cells after Delta-24-RGD treatment, may have utility as an early surrogate of a robust systemic immune response that correlates with long-term survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DW的应助被YW采纳,获得10
刚刚
刚刚
十一发布了新的文献求助10
刚刚
1秒前
田様的应助被小马哥采纳,获得10
1秒前
1秒前
Ariel发布了新的文献求助10
1秒前
是快乐的小赵啊完成签到,获得积分10
1秒前
DW的应助被545采纳,获得10
2秒前
熙攘发布了新的文献求助10
2秒前
科研通AI2S的应助被唐宇航采纳,获得10
3秒前
3秒前
3秒前
共享精神的应助被Code_king采纳,获得10
3秒前
3秒前
赘婿的应助被Code_king采纳,获得10
3秒前
3秒前
Sussie发布了新的文献求助20
3秒前
华仔的应助被Code_king采纳,获得10
4秒前
可爱的函函的应助被Code_king采纳,获得10
4秒前
4秒前
脑洞疼的应助被Code_king采纳,获得10
4秒前
4秒前
4秒前
orixero的应助被Code_king采纳,获得10
4秒前
AlvinCZY完成签到,获得积分10
4秒前
AAAAAAAAAAA发布了新的文献求助10
4秒前
4秒前
小蘑菇的应助被Code_king采纳,获得10
4秒前
5秒前
Hello的应助被研友_bZzJqZ采纳,获得30
5秒前
小蘑菇的应助被Code_king采纳,获得10
5秒前
搜集达人的应助被Code_king采纳,获得10
5秒前
5秒前
安静的十八完成签到,获得积分10
5秒前
小石头发布了新的文献求助10
6秒前
7秒前
Orange的应助被小羊采纳,获得10
7秒前
7秒前
AaKunn完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176287
求助须知:如何正确求助?哪些是违规求助? 9567719
关于积分的说明 21794359
捐赠科研通 7771008
什么是DOI,文献DOI怎么找? 3431998
关于科研通互助平台的介绍 2556315
邀请新用户注册赠送积分活动 2477650